Sreelakshmi Kolli - May 12, 2023 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)

Role
Director
Signature
/s/ Matthew R. St. Louis, Attorney-in-Fact for Sreelakshmi Kolli (power of attorney previously filed)
Stock symbol
ZBH
Transactions as of
May 12, 2023
Transactions value $
$0
Form type
4
Date filed
5/16/2023, 04:15 PM
Previous filing
Apr 4, 2023
Next filing
Jul 12, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZBH Phantom Stock Units Award $0 +500 +25.01% $0.00 2.5K May 12, 2023 Common Stock 500 $136.73 Direct F1, F2, F3, F4
transaction ZBH Restricted Stock Units Award $0 +951 +49.18% $0.00 2.88K May 12, 2023 Common Stock 951 Direct F2, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.
F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
F3 These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
F4 Includes 3.274 phantom stock units accrued on April 28, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
F5 The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
F6 Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.